UTI AMC Q1 Consolidated Profit Rises 24% to ₹294 Crore on Fair Value Gains
UTI AMC reported a 24% YoY rise in consolidated net profit to ₹294 crore for Q1FY27, driven by fair value gains of ₹187 crore, with total income at ₹585 crore. On a standalone basis, revenue from operations was ₹438 crore and net profit was ₹218 crore. The board approved results on July 22, 2026, and shareholders approved a final dividend of ₹40 per share.

*this image is generated using AI for illustrative purposes only.
UTI Asset Management Company Limited reported a consolidated net profit of ₹294 crore for the quarter ended June 30, 2026, representing a 24% increase compared to ₹237 crore in the corresponding period of the previous year. The asset manager's revenue from operations grew to ₹584 crore from ₹547 crore in Q1FY26, primarily driven by a net gain on fair value changes which amounted to ₹187 crore. On a standalone basis, the company recorded a profit of ₹218 crore for the quarter, slightly higher than the ₹216 crore reported in the same quarter last year.
Financial Performance
The company's total income on a consolidated basis stood at ₹585 crore for Q1FY27, up from ₹549 crore in the prior year. Total expenses for the quarter were ₹217 crore, a marginal decrease from ₹223 crore in Q1FY26. The profit before tax for the quarter was ₹368 crore, compared to ₹326 crore in the previous year. The basic earnings per share (EPS) for the quarter increased to ₹22.86 from ₹18.50 in the year-ago period.
Consolidated Financial Results (₹ in crore)
| Particulars: | Q1FY27 (Unaudited) | Q1FY26 (Unaudited) |
|---|---|---|
| Total revenue from operations | 584 | 547 |
| Total income | 585 | 549 |
| Total expenses | 217 | 223 |
| Profit for the period | 294 | 237 |
| Basic EPS (₹) | 22.86 | 18.50 |
Standalone Results
In its standalone financial results, UTI AMC posted a total revenue from operations of ₹438 crore for the quarter ended June 30, 2026, compared to ₹437 crore in the same quarter of the previous year. The standalone profit for the period was ₹218 crore, while the total comprehensive income for the quarter stood at ₹205 crore. The standalone basic EPS was reported at ₹16.95.
Operational Details
The Board of Directors approved the unaudited standalone and consolidated financial results in its meeting held on July 22, 2026. The results were subjected to a limited review by the statutory auditors, B S R & Co. LLP. During the quarter, the company allotted 5,302 equity shares of face value ₹10 each pursuant to the exercise of stock options. Additionally, shareholders approved a final dividend of ₹40 per equity share at the Annual General Meeting held on July 21, 2026.
The company's consolidated financial results include the performance of subsidiaries such as UTI International Limited, UTI Pension Fund Limited, and UTI Alternatives Private Limited. The geographical revenue data indicates that the Domestic Segment (India) contributed ₹353.33 crore, while the International Segment contributed ₹25.41 crore to the total revenue from operations for the quarter.
Historical Stock Returns for UTI AMC
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.04% | -7.73% | -2.88% | -12.06% | -38.17% | +1.09% |
How sustainable is the 24% profit growth given the reliance on net gains from fair value changes?
What strategies is UTI AMC pursuing to boost the revenue contribution from its International Segment?
Will the company maintain the current dividend payout ratio of ₹40 per share in the upcoming quarters?


































